Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
apalutamide, Quantity: 60 mg
Janssen-Cilag Pty Ltd
Tablet, film coated
Excipient Ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; hypromellose acetate succinate; croscarmellose sodium; silicified microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; iron oxide black
Oral
120 tablets
(S4) Prescription Only Medicine
JANSSEN APALUTAMIDE (apalutamide) is indicated for the treatment of patients with: ? metastatic castration-sensitive prostate cancer (mCSPC) or ? non-metastatic, castration-resistant prostate cancer (nmCRPC).
Visual Identification: Slightly yellowish green to greyish green, oblong-shaped, film-coated tablets, debossed with AR 60 on one side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Registered
2018-07-05